Qualitative analysis of microbial contamination of inhalers

Fraser Adam Mabbott, Alexander Mullen, A. Smith, G. Smith, Anne Boyter

Research output: Contribution to journalLetter

3 Citations (Scopus)

Abstract

Inhalation is the principal drug delivery route for treatment of respiratory conditions including asthma and chronic obstructive pulmonary disease, with a quick onset of action and reduced adverse effects being the major advantages over systemic drug delivery.1 Placebo inhaler devices are used to teach inhaler technique by allowing patients to gain experience of how inhalers operate and healthcare professionals to assess technique. Placebo inhaler devices are labelled as ‘single use’ items and are recommended as ‘individual use’ in patient information leaflets, although re-use of these devices has been advocated.2 M. Richardson, S. Wyllie, A. Dennis and C. Fehrenbach, Reducing the risk: the use of placebo respiratory equipment in clinical practice, J Infect Prev 10 (2009), pp. 14–20. View Record in Scopus | Cited By in Scopus (1)2 Re-use of inhaler devices may lead to contamination and cross-contamination.[3] and [4] Standard cleaning procedures for placebo devices are elusive. For medicine-containing inhalers, patient information leaflets recommend weekly cleaning with a dry cloth, to prevent the inhaler from blocking but not for microbial disinfection. It is questioned whether more efficacious cleaning procedures are needed. Little research has been conducted on the cleaning procedures of inhalers at present. Contamination of respiratory devices other than inhalers has been well documented with up to 30% of spacers and 65% of nebulisers contaminated.[5], [6] and [7] The contaminants were predominantly Bacillus spp. and Pseudomonas spp.. There is little research into the contamination of placebo devices.
Original languageEnglish
Pages (from-to)277-278
Number of pages2
JournalJournal of Hospital Infection
Volume77
Issue number3
DOIs
Publication statusPublished - Mar 2011

Fingerprint

Nebulizers and Vaporizers
Equipment and Supplies
Placebos
Disinfection
Pseudomonas
Research
Pharmaceutical Preparations
Chronic Obstructive Pulmonary Disease
Bacillus
Inhalation
Asthma
Medicine
Delivery of Health Care

Keywords

  • infection
  • inhalers
  • contamination
  • drug delivery

Cite this

Mabbott, Fraser Adam ; Mullen, Alexander ; Smith, A. ; Smith, G. ; Boyter, Anne. / Qualitative analysis of microbial contamination of inhalers. In: Journal of Hospital Infection. 2011 ; Vol. 77, No. 3. pp. 277-278.
@article{c09a6cd067784759b157c358187e68f5,
title = "Qualitative analysis of microbial contamination of inhalers",
abstract = "Inhalation is the principal drug delivery route for treatment of respiratory conditions including asthma and chronic obstructive pulmonary disease, with a quick onset of action and reduced adverse effects being the major advantages over systemic drug delivery.1 Placebo inhaler devices are used to teach inhaler technique by allowing patients to gain experience of how inhalers operate and healthcare professionals to assess technique. Placebo inhaler devices are labelled as ‘single use’ items and are recommended as ‘individual use’ in patient information leaflets, although re-use of these devices has been advocated.2 M. Richardson, S. Wyllie, A. Dennis and C. Fehrenbach, Reducing the risk: the use of placebo respiratory equipment in clinical practice, J Infect Prev 10 (2009), pp. 14–20. View Record in Scopus | Cited By in Scopus (1)2 Re-use of inhaler devices may lead to contamination and cross-contamination.[3] and [4] Standard cleaning procedures for placebo devices are elusive. For medicine-containing inhalers, patient information leaflets recommend weekly cleaning with a dry cloth, to prevent the inhaler from blocking but not for microbial disinfection. It is questioned whether more efficacious cleaning procedures are needed. Little research has been conducted on the cleaning procedures of inhalers at present. Contamination of respiratory devices other than inhalers has been well documented with up to 30{\%} of spacers and 65{\%} of nebulisers contaminated.[5], [6] and [7] The contaminants were predominantly Bacillus spp. and Pseudomonas spp.. There is little research into the contamination of placebo devices.",
keywords = "infection, inhalers, contamination, drug delivery",
author = "Mabbott, {Fraser Adam} and Alexander Mullen and A. Smith and G. Smith and Anne Boyter",
year = "2011",
month = "3",
doi = "10.1016/j.jhin.2010.11.005",
language = "English",
volume = "77",
pages = "277--278",
journal = "Journal of Hospital Infection",
issn = "0195-6701",
number = "3",

}

Qualitative analysis of microbial contamination of inhalers. / Mabbott, Fraser Adam; Mullen, Alexander; Smith, A.; Smith, G.; Boyter, Anne.

In: Journal of Hospital Infection, Vol. 77, No. 3, 03.2011, p. 277-278.

Research output: Contribution to journalLetter

TY - JOUR

T1 - Qualitative analysis of microbial contamination of inhalers

AU - Mabbott, Fraser Adam

AU - Mullen, Alexander

AU - Smith, A.

AU - Smith, G.

AU - Boyter, Anne

PY - 2011/3

Y1 - 2011/3

N2 - Inhalation is the principal drug delivery route for treatment of respiratory conditions including asthma and chronic obstructive pulmonary disease, with a quick onset of action and reduced adverse effects being the major advantages over systemic drug delivery.1 Placebo inhaler devices are used to teach inhaler technique by allowing patients to gain experience of how inhalers operate and healthcare professionals to assess technique. Placebo inhaler devices are labelled as ‘single use’ items and are recommended as ‘individual use’ in patient information leaflets, although re-use of these devices has been advocated.2 M. Richardson, S. Wyllie, A. Dennis and C. Fehrenbach, Reducing the risk: the use of placebo respiratory equipment in clinical practice, J Infect Prev 10 (2009), pp. 14–20. View Record in Scopus | Cited By in Scopus (1)2 Re-use of inhaler devices may lead to contamination and cross-contamination.[3] and [4] Standard cleaning procedures for placebo devices are elusive. For medicine-containing inhalers, patient information leaflets recommend weekly cleaning with a dry cloth, to prevent the inhaler from blocking but not for microbial disinfection. It is questioned whether more efficacious cleaning procedures are needed. Little research has been conducted on the cleaning procedures of inhalers at present. Contamination of respiratory devices other than inhalers has been well documented with up to 30% of spacers and 65% of nebulisers contaminated.[5], [6] and [7] The contaminants were predominantly Bacillus spp. and Pseudomonas spp.. There is little research into the contamination of placebo devices.

AB - Inhalation is the principal drug delivery route for treatment of respiratory conditions including asthma and chronic obstructive pulmonary disease, with a quick onset of action and reduced adverse effects being the major advantages over systemic drug delivery.1 Placebo inhaler devices are used to teach inhaler technique by allowing patients to gain experience of how inhalers operate and healthcare professionals to assess technique. Placebo inhaler devices are labelled as ‘single use’ items and are recommended as ‘individual use’ in patient information leaflets, although re-use of these devices has been advocated.2 M. Richardson, S. Wyllie, A. Dennis and C. Fehrenbach, Reducing the risk: the use of placebo respiratory equipment in clinical practice, J Infect Prev 10 (2009), pp. 14–20. View Record in Scopus | Cited By in Scopus (1)2 Re-use of inhaler devices may lead to contamination and cross-contamination.[3] and [4] Standard cleaning procedures for placebo devices are elusive. For medicine-containing inhalers, patient information leaflets recommend weekly cleaning with a dry cloth, to prevent the inhaler from blocking but not for microbial disinfection. It is questioned whether more efficacious cleaning procedures are needed. Little research has been conducted on the cleaning procedures of inhalers at present. Contamination of respiratory devices other than inhalers has been well documented with up to 30% of spacers and 65% of nebulisers contaminated.[5], [6] and [7] The contaminants were predominantly Bacillus spp. and Pseudomonas spp.. There is little research into the contamination of placebo devices.

KW - infection

KW - inhalers

KW - contamination

KW - drug delivery

UR - http://www.scopus.com/inward/record.url?scp=79951856954&partnerID=8YFLogxK

U2 - 10.1016/j.jhin.2010.11.005

DO - 10.1016/j.jhin.2010.11.005

M3 - Letter

VL - 77

SP - 277

EP - 278

JO - Journal of Hospital Infection

JF - Journal of Hospital Infection

SN - 0195-6701

IS - 3

ER -